celastrol methyl ester has been researched along with pyrazolanthrone in 1 studies
Studies (celastrol methyl ester) | Trials (celastrol methyl ester) | Recent Studies (post-2010) (celastrol methyl ester) | Studies (pyrazolanthrone) | Trials (pyrazolanthrone) | Recent Studies (post-2010) (pyrazolanthrone) |
---|---|---|---|---|---|
39 | 0 | 27 | 1,484 | 2 | 765 |
Protein | Taxonomy | celastrol methyl ester (IC50) | pyrazolanthrone (IC50) |
---|---|---|---|
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
Chain A, Mitogen-activated protein kinase 10 | Homo sapiens (human) | 0.15 | |
TPA: protein transporter TIM10 | Saccharomyces cerevisiae S288C | 20.2 | |
TPA: protein transporter TIM23 | Saccharomyces cerevisiae S288C | 6.31 | |
Serine/threonine-protein kinase/endoribonuclease IRE1 | Homo sapiens (human) | 0.72 | |
Interferon-induced, double-stranded RNA-activated protein kinase | Homo sapiens (human) | 8 | |
Dual specificity protein kinase TTK | Homo sapiens (human) | 0.8987 | |
Mitogen-activated protein kinase 8 | Homo sapiens (human) | 0.921 | |
Mitogen-activated protein kinase 9 | Homo sapiens (human) | 1.0111 | |
Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 0.957 | |
Mitogen-activated protein kinase 10 | Homo sapiens (human) | 1.4193 | |
Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.15 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ahmad, F; Al-Tamimi, M; Alam, M; Anver, R; Buddenkotte, J; Khan, AQ; M Mateo, J; Raza, SS; Steinhoff, M; Uddin, S | 1 |
1 other study(ies) available for celastrol methyl ester and pyrazolanthrone
Article | Year |
---|---|
Pristimerin mediated anticancer effects and sensitization of human skin cancer cells through modulation of MAPK signaling pathways.
Topics: Carcinoma, Squamous Cell; Humans; MAP Kinase Signaling System; Reactive Oxygen Species; Skin Neoplasms | 2022 |